Ulcerative

·MeSH: Ulcer

98 drugs in development·46 companies·1 clinical trial

Get the AI investment thesis on Ulcerative

Drug Pipeline by Phase

Approved(17)

Drug	Company
abrilada	PFIZER INC (PFE) Analyze with AI →
Hadlima (SB5)	Organon & Co. (OGN) Analyze with AI →
imuldosa	Acorda Therapeutics, Inc. (ACOR) Analyze with AI →
inFoods® (IBS)	BIOMERICA INC (BMRA) Analyze with AI →
lodonal	Biostax Corp. (BTAX) Analyze with AI →
mesalamine	Mylan II B.V. (MYL) Analyze with AI →
mesalamine	Amneal Pharmaceuticals, Inc. (AMRX) Analyze with AI →
Omvoh	ELI LILLY & Co (LLY) Analyze with AI →
OmvohTM	ELI LILLY & Co (LLY) Analyze with AI →
Renflexis (SB2)	Organon & Co. (OGN) Analyze with AI →
Tremfya	Royalty Pharma plc (RPRX) Analyze with AI →
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA) Analyze with AI →
Uceris authorized generic	Bausch Health Companies Inc. (BHC) Analyze with AI →
velsipity	PFIZER INC (PFE) Analyze with AI →
wezlana	AMGEN INC (AMGN) Analyze with AI →
xeljanz xr	PFIZER INC (PFE) Analyze with AI →
yesintek	Bone Biologics Corp (BBLG) Analyze with AI →

Phase 3(22)

Drug	Company
abx464	Abivax SA (ABVX) Analyze with AI →
ABX464	Abivax SA (ABVX) Analyze with AI →
brazikumab induction dose	ASTRAZENECA PLC (AZN) Analyze with AI →
brazikumab maintenance dose	ASTRAZENECA PLC (AZN) Analyze with AI →
duvakitug	Sanofi (SNYNF) Analyze with AI →
duvakitug	Sanofi (SNY) Analyze with AI →
etrasimod	PFIZER INC (PFE) Analyze with AI →
golimumab	GH Research PLC (GHRS) Analyze with AI →
infliximab	GH Research PLC (GHRS) Analyze with AI →
IV Tulisokibart	Merck & Co., Inc. (MRK) Analyze with AI →
Mirikizumab	ELI LILLY & Co (LLY) Analyze with AI →
Mirikizumab IV	ELI LILLY & Co (LLY) Analyze with AI →
Mirikizumab SC	ELI LILLY & Co (LLY) Analyze with AI →
one dose of surfactant replacement	GH Research PLC (GHRS) Analyze with AI →
ozanimod	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →
ozanimod	CELGENE CORP /DE/ (CELG) Analyze with AI →
SC Tulisokibart	Merck & Co., Inc. (MRK) Analyze with AI →
tak-279	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
Tulisokibart	Merck & Co., Inc. (MRK) Analyze with AI →
Vedolizumab	AbbVie Inc. (ABBV) Analyze with AI →
vedolizumab iv	TAKEDA PHARMACEUTICAL CO LTD (TKPHF) Analyze with AI →
vedolizumab sc	TAKEDA PHARMACEUTICAL CO LTD (TKPHF) Analyze with AI →

Phase 2(29)

Drug	Company
av7909 half dose	GH Research PLC (GHRS) Analyze with AI →
balinatunfib	Sanofi (SNY) Analyze with AI →
balinatunfib	Sanofi (SNY) Analyze with AI →
bertilimumab	IMMUNE PHARMACEUTICALS INC (IMNP) Analyze with AI →
Eltrekibart	ELI LILLY & Co (LLY) Analyze with AI →
emvistegrast	GILEAD SCIENCES, INC. (GILD) Analyze with AI →
fxr314	VivoSim Labs, INC. (VIVS) Analyze with AI →
JNJ-77242113	Crinetics Pharmaceuticals, Inc. (CRNX) Analyze with AI →
LY4268989	ELI LILLY & Co (LLY) Analyze with AI →
ly4395089	ELI LILLY & Co (LLY) Analyze with AI →
met642	Metacrine, Inc. (MTCR) Analyze with AI →
mirikizumab -	ELI LILLY & Co (LLY) Analyze with AI →
morf-057	Morphic Holding, Inc. (MORF) Analyze with AI →
nx-13	Landos Biopharma, Inc. (LABP) Analyze with AI →
nx-13	AbbVie Inc. (ABBV) Analyze with AI →
od-07656	Odyssey Health, Inc. (ODYY) Analyze with AI →
pl8177	PALATIN TECHNOLOGIES INC (PTN) Analyze with AI →
Rosnilimab	ANAPTYSBIO, INC (ANAB) Analyze with AI →
sar442970	Sanofi (SNY) Analyze with AI →
SAR442970	Sanofi (SNY) Analyze with AI →
sar443122	Sanofi (SNY) Analyze with AI →
sar443122	Sanofi (SNYNF) Analyze with AI →
SER-287	Seres Therapeutics, Inc. (MCRB) Analyze with AI →
SPY001	Spyre Therapeutics, Inc. (SYRE) Analyze with AI →
SPY002	Spyre Therapeutics, Inc. (SYRE) Analyze with AI →
SPY003	Spyre Therapeutics, Inc. (SYRE) Analyze with AI →
tak-279	TAKEDA PHARMACEUTICAL CO LTD (TKPHF) Analyze with AI →
tamuzimod	Ventyx Biosciences, Inc. (VTYX) Analyze with AI →
vedolizumab	Odyssey Health, Inc. (ODYY) Analyze with AI →

Phase 1(4)

Drug	Company
bt-600	BIORA THERAPEUTICS, INC. (BIOR) Analyze with AI →
pali-2108	PALISADE BIO, INC. (PALI) Analyze with AI →
pt101	Pandion Therapeutics, Inc. (PAND) Analyze with AI →
SER-301	Seres Therapeutics, Inc. (MCRB) Analyze with AI →

Preclinical(5)

Drug	Company
bt-001	BIORA THERAPEUTICS, INC. (BIOR) Analyze with AI →
eq504	Equillium, Inc. (EQ) Analyze with AI →
kb295	Kaleido Biosciences, Inc. (KLDO) Analyze with AI →
ser-603	Seres Therapeutics, Inc. (MCRB) Analyze with AI →
zegocractin (oral, preclinical administration)	CalciMedica, Inc. (CALC) Analyze with AI →

Unknown(4)

Drug	Company
azathioprine	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →
CLS-001	Comera Life Sciences Holdings, Inc. (CMRA) Analyze with AI →
InFoods® platform (other disease targets)	BIOMERICA INC (BMRA) Analyze with AI →
Non-Interventional Study	PFIZER INC (PFE) Analyze with AI →

BLA Filed(1)

Drug	Company
m923	MOMENTA PHARMACEUTICALS INC (MNTA) Analyze with AI →

Phase 1/Phase 2(1)

Drug	Company
XmAb942	Xencor Inc (XNCR) Analyze with AI →

Phase 2/Phase 3(2)

Drug	Company
av7909 full dose	GH Research PLC (GHRS) Analyze with AI →
full dose mdma	GH Research PLC (GHRS) Analyze with AI →

Phase 4(13)

Drug	Company
brazikumab	ASTRAZENECA PLC (AZN) Analyze with AI →
Risankizumab	AbbVie Inc. (ABBV) Analyze with AI →
treatment with amiodarone at a dose 100 mg per day	GH Research PLC (GHRS) Analyze with AI →
treatment with amiodarone at a dose 400 mg per day	GH Research PLC (GHRS) Analyze with AI →
vedolizumab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab	TAKEDA PHARMACEUTICAL CO LTD (TKPHF) Analyze with AI →
vedolizumab iv	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab iv	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab iv	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab sc	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →
vedolizumab sc	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Analyze with AI →

Compare drugs

abrilada vs Hadlima (SB5)abrilada vs imuldosa abrilada vs inFoods® (IBS)

Frequently asked questions

How many drugs are in development for Ulcerative?

BioSniper tracks 98 drugs in development for Ulcerative across 46 companies.

How many clinical trials target Ulcerative?

There are 1 clinical trial targeting Ulcerative tracked by BioSniper.

Analyze PFIZER INC's Ulcerative pipeline with AI

Full trial data, competitive analysis, and AI-powered pipeline tracking.

200 free AI credits / month to run live multi-agent analysis
Watchlist, catalyst alerts & the biotech event calendar
Full pipeline, financials & FDA data on every company

Start AI Analysis